{"id":"W2761835542","doi":"10.1093/annonc/mdx374.056","title":"Pembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Placebo; Regimen; Internal medicine; Head and neck squamous-cell carcinoma; Oncology; Surgery; Radiation therapy; Head and neck cancer; Immunotherapy; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001239196,0.001014097,0.001335576,0.0001964353,0.0003840749,0.000818065,0.0007873436,0.0008619949,0.004944172],"category_scores_gemma":[0.0007071233,0.0003515841,0.001372816,0.0002990795,0.0005022735,0.0009352085,0.0003748844,0.003082808,0.001045363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001049519,"about_ca_system_score_gemma":0.001188989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001759482,"about_ca_topic_score_gemma":0.007012785,"domain_scores_codex":[0.9997968,0.00008144653,0.000007297969,0.00004262866,0.00001953189,0.00005227288],"domain_scores_gemma":[0.9997435,0.00004990911,0.00004673956,0.00002170294,0.00001843092,0.0001197158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7641676,0.0149596,0.003008331,0.002933573,0.00321211,0.0002241075,0.0002743571,0.003875427,0.01771429,0.000887541,0.02137499,0.167368],"study_design_scores_gemma":[0.886845,0.09231255,0.008629443,0.0001421787,0.00118928,0.000258874,0.00009369977,0.001479983,0.001397169,0.0006530153,0.006966693,0.00003216374],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9722884,0.01055567,0.0007580299,0.001868924,0.0005131758,0.002637109,0.003364576,0.0002349161,0.007779007],"genre_scores_gemma":[0.9750742,0.00605193,0.002140235,0.002420793,0.0002483578,0.002420235,0.003713327,0.00005004944,0.007880953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004944172,"threshold_uncertainty_score":0.01653993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0787968731189083,"score_gpt":0.4089477882456363,"score_spread":0.330150915126728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}